A major legal dispute is on the horizon as the Bank Policy Institute evaluates taking the OCC to court over crypto-related licensing. The BPI, whose board includes CEOs from Citigroup and Bank of America, is protesting a new regulatory framework they say favors fintech upstarts. They believe these changes undermine the safety and soundness of the national banking system by allowing firms to avoid traditional oversight.
The OCC has recently made it easier for crypto companies to obtain national bank trust charters, a move that provides them with a federal stamp of approval. This initiative is widely perceived as part of an effort to bring decentralized finance into the mainstream American economy. However, traditional lenders argue that this “fast-track” approach ignores the complexities and risks associated with digital asset firms.
Large-scale payment and blockchain firms like Wise, Circle, and Ripple are among those seeking these new federal licenses. The BPI has explicitly called for the rejection of these applications, arguing that a “lighter regulatory touch” is inappropriate for firms offering bank-like products. The involvement of a crypto firm linked to the Trump family has further polarized the discussion among lawmakers and industry experts.
This battle is a pivotal moment for the U.S. economy, as it defines the boundary between traditional finance and emerging tech. If the OCC’s rules stand, it could lead to a massive shift in how financial services are delivered and regulated across the country. Community banks and state-level regulators are also standing in opposition, citing concerns over unfair competition and reduced consumer safety.
The BPI has a history of successfully challenging federal regulators, as seen in their recent legal victory over the Federal Reserve’s stress tests. A similar strategy against the OCC could force the agency to rethink its pro-crypto stance or face a long-term judicial freeze. The financial community is now waiting to see if the lobby group will pull the trigger on a formal complaint.